Nucleoside Analogs That Inhibit SARS-CoV-2 Replication by Blocking Interaction of Virus Polymerase with RNA

The SARS-CoV-2 betacoronavirus pandemic has claimed more than 6.5 million lives and, despite the development and use of COVID-19 vaccines, remains a major global public health problem. The development of specific drugs for the treatment of this disease remains a very urgent task. In the context of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Matyugina, Elena, Petushkov, Ivan, Surzhikov, Sergei, Kezin, Vasily, Maslova, Anna, Ivanova, Olga, Smirnova, Olga, Kirillov, Ilya, Fedyakina, Irina, Kulbachinskiy, Andrey, Kochetkov, Sergey, Khandazhinskaya, Anastasia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959748/
https://www.ncbi.nlm.nih.gov/pubmed/36834771
http://dx.doi.org/10.3390/ijms24043361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959748/
https://www.ncbi.nlm.nih.gov/pubmed/36834771
http://dx.doi.org/10.3390/ijms24043361

Ejemplares similares